
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Complement in cancer: untangling an intricate relationship
Edimara S. Reis, Dimitrios C. Mastellos, Daniel Ricklin, et al.
Nature reviews. Immunology (2017) Vol. 18, Iss. 1, pp. 5-18
Open Access | Times Cited: 351
Edimara S. Reis, Dimitrios C. Mastellos, Daniel Ricklin, et al.
Nature reviews. Immunology (2017) Vol. 18, Iss. 1, pp. 5-18
Open Access | Times Cited: 351
Showing 1-25 of 351 citing articles:
Diversity, Mechanisms, and Significance of Macrophage Plasticity
Massimo Locati, Graziella Curtale, Alberto Mantovani
Annual Review of Pathology Mechanisms of Disease (2019) Vol. 15, Iss. 1, pp. 123-147
Open Access | Times Cited: 1486
Massimo Locati, Graziella Curtale, Alberto Mantovani
Annual Review of Pathology Mechanisms of Disease (2019) Vol. 15, Iss. 1, pp. 123-147
Open Access | Times Cited: 1486
Macrophages as tools and targets in cancer therapy
Alberto Mantovani, Paola Allavena, Federica Marchesi, et al.
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 11, pp. 799-820
Open Access | Times Cited: 1101
Alberto Mantovani, Paola Allavena, Federica Marchesi, et al.
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 11, pp. 799-820
Open Access | Times Cited: 1101
CD10+GPR77+ Cancer-Associated Fibroblasts Promote Cancer Formation and Chemoresistance by Sustaining Cancer Stemness
Shicheng Su, Jianing Chen, Herui Yao, et al.
Cell (2018) Vol. 172, Iss. 4, pp. 841-856.e16
Open Access | Times Cited: 1017
Shicheng Su, Jianing Chen, Herui Yao, et al.
Cell (2018) Vol. 172, Iss. 4, pp. 841-856.e16
Open Access | Times Cited: 1017
Neutrophil diversity and plasticity in tumour progression and therapy
Sébastien Jaillon, Andrea Ponzetta, Diletta Di Mitri, et al.
Nature reviews. Cancer (2020) Vol. 20, Iss. 9, pp. 485-503
Closed Access | Times Cited: 866
Sébastien Jaillon, Andrea Ponzetta, Diletta Di Mitri, et al.
Nature reviews. Cancer (2020) Vol. 20, Iss. 9, pp. 485-503
Closed Access | Times Cited: 866
Novel mechanisms and functions of complement
George Hajishengallis, Edimara S. Reis, Dimitrios C. Mastellos, et al.
Nature Immunology (2017) Vol. 18, Iss. 12, pp. 1288-1298
Open Access | Times Cited: 441
George Hajishengallis, Edimara S. Reis, Dimitrios C. Mastellos, et al.
Nature Immunology (2017) Vol. 18, Iss. 12, pp. 1288-1298
Open Access | Times Cited: 441
Wnt signaling in breast cancer: biological mechanisms, challenges and opportunities
Xiufang Xu, Miaofeng Zhang, Faying Xu, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 411
Xiufang Xu, Miaofeng Zhang, Faying Xu, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 411
Myeloid immunosuppression and immune checkpoints in the tumor microenvironment
Kyohei Nakamura, Mark J. Smyth
Cellular and Molecular Immunology (2019) Vol. 17, Iss. 1, pp. 1-12
Open Access | Times Cited: 398
Kyohei Nakamura, Mark J. Smyth
Cellular and Molecular Immunology (2019) Vol. 17, Iss. 1, pp. 1-12
Open Access | Times Cited: 398
DNA methylation loss promotes immune evasion of tumours with high mutation and copy number load
Hyunchul Jung, Hong Sook Kim, Jeong Yeon Kim, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 393
Hyunchul Jung, Hong Sook Kim, Jeong Yeon Kim, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 393
New insights into the immune functions of complement
Edimara S. Reis, Dimitrios C. Mastellos, George Hajishengallis, et al.
Nature reviews. Immunology (2019) Vol. 19, Iss. 8, pp. 503-516
Open Access | Times Cited: 389
Edimara S. Reis, Dimitrios C. Mastellos, George Hajishengallis, et al.
Nature reviews. Immunology (2019) Vol. 19, Iss. 8, pp. 503-516
Open Access | Times Cited: 389
The renaissance of complement therapeutics
Daniel Ricklin, Dimitrios C. Mastellos, Edimara S. Reis, et al.
Nature Reviews Nephrology (2017) Vol. 14, Iss. 1, pp. 26-47
Open Access | Times Cited: 339
Daniel Ricklin, Dimitrios C. Mastellos, Edimara S. Reis, et al.
Nature Reviews Nephrology (2017) Vol. 14, Iss. 1, pp. 26-47
Open Access | Times Cited: 339
Metal Drugs and the Anticancer Immune Response
Bernhard Englinger, Christine Pirker, Petra Heffeter, et al.
Chemical Reviews (2018) Vol. 119, Iss. 2, pp. 1519-1624
Open Access | Times Cited: 304
Bernhard Englinger, Christine Pirker, Petra Heffeter, et al.
Chemical Reviews (2018) Vol. 119, Iss. 2, pp. 1519-1624
Open Access | Times Cited: 304
Clinical promise of next-generation complement therapeutics
Dimitrios C. Mastellos, Daniel Ricklin, John D. Lambris
Nature Reviews Drug Discovery (2019) Vol. 18, Iss. 9, pp. 707-729
Open Access | Times Cited: 292
Dimitrios C. Mastellos, Daniel Ricklin, John D. Lambris
Nature Reviews Drug Discovery (2019) Vol. 18, Iss. 9, pp. 707-729
Open Access | Times Cited: 292
Context-dependent roles of complement in cancer
Lubka T. Roumenina, Marie V. Daugan, Florent Petitprez, et al.
Nature reviews. Cancer (2019) Vol. 19, Iss. 12, pp. 698-715
Open Access | Times Cited: 283
Lubka T. Roumenina, Marie V. Daugan, Florent Petitprez, et al.
Nature reviews. Cancer (2019) Vol. 19, Iss. 12, pp. 698-715
Open Access | Times Cited: 283
Targeting cancer-promoting inflammation — have anti-inflammatory therapies come of age?
Jiajie Hou, Michael Karin, Beicheng Sun
Nature Reviews Clinical Oncology (2021) Vol. 18, Iss. 5, pp. 261-279
Open Access | Times Cited: 261
Jiajie Hou, Michael Karin, Beicheng Sun
Nature Reviews Clinical Oncology (2021) Vol. 18, Iss. 5, pp. 261-279
Open Access | Times Cited: 261
Complement Signals Determine Opposite Effects of B Cells in Chemotherapy-Induced Immunity
Yiwen Lu, Qiyi Zhao, Jian‐You Liao, et al.
Cell (2020) Vol. 180, Iss. 6, pp. 1081-1097.e24
Open Access | Times Cited: 220
Yiwen Lu, Qiyi Zhao, Jian‐You Liao, et al.
Cell (2020) Vol. 180, Iss. 6, pp. 1081-1097.e24
Open Access | Times Cited: 220
Tumor-associated macrophages in cancer: recent advancements in cancer nanoimmunotherapies
Nisha Kumari, Seung Hong Choi
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 215
Nisha Kumari, Seung Hong Choi
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 215
Age and Sex-Associated Changes of Complement Activity and Complement Levels in a Healthy Caucasian Population
Mariana Gaya da Costa, Felix Poppelaars, Cees van Kooten, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 212
Mariana Gaya da Costa, Felix Poppelaars, Cees van Kooten, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 212
Tumor Cells Hijack Macrophage-Produced Complement C1q to Promote Tumor Growth
Lubka T. Roumenina, Marie V. Daugan, Rémi Noé, et al.
Cancer Immunology Research (2019) Vol. 7, Iss. 7, pp. 1091-1105
Open Access | Times Cited: 209
Lubka T. Roumenina, Marie V. Daugan, Rémi Noé, et al.
Cancer Immunology Research (2019) Vol. 7, Iss. 7, pp. 1091-1105
Open Access | Times Cited: 209
Complementing the Cancer-Immunity Cycle
Rubén Pı́o, Daniel Ajona, Sergio Ortiz‐Espinosa, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 174
Rubén Pı́o, Daniel Ajona, Sergio Ortiz‐Espinosa, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 174
Tumor-associated myeloid cells: diversity and therapeutic targeting
Alberto Mantovani, Federica Marchesi, Sébastien Jaillon, et al.
Cellular and Molecular Immunology (2021) Vol. 18, Iss. 3, pp. 566-578
Open Access | Times Cited: 154
Alberto Mantovani, Federica Marchesi, Sébastien Jaillon, et al.
Cellular and Molecular Immunology (2021) Vol. 18, Iss. 3, pp. 566-578
Open Access | Times Cited: 154
Biological Functions and Analytical Strategies of Sialic Acids in Tumor
Xiaoman Zhou, Ganglong Yang, Feng Guan
Cells (2020) Vol. 9, Iss. 2, pp. 273-273
Open Access | Times Cited: 143
Xiaoman Zhou, Ganglong Yang, Feng Guan
Cells (2020) Vol. 9, Iss. 2, pp. 273-273
Open Access | Times Cited: 143
Mechanisms of Therapeutic Antitumor Monoclonal Antibodies
Li-Chung Tsao, Jeremy Force, Zachary C. Hartman
Cancer Research (2021) Vol. 81, Iss. 18, pp. 4641-4651
Open Access | Times Cited: 142
Li-Chung Tsao, Jeremy Force, Zachary C. Hartman
Cancer Research (2021) Vol. 81, Iss. 18, pp. 4641-4651
Open Access | Times Cited: 142
Tipping the balance: intricate roles of the complement system in disease and therapy
Richard B. Pouw, Daniel Ricklin
Seminars in Immunopathology (2021) Vol. 43, Iss. 6, pp. 757-771
Open Access | Times Cited: 115
Richard B. Pouw, Daniel Ricklin
Seminars in Immunopathology (2021) Vol. 43, Iss. 6, pp. 757-771
Open Access | Times Cited: 115
Complosome — the intracellular complement system
Erin E. West, Claudia Kemper
Nature Reviews Nephrology (2023) Vol. 19, Iss. 7, pp. 426-439
Open Access | Times Cited: 111
Erin E. West, Claudia Kemper
Nature Reviews Nephrology (2023) Vol. 19, Iss. 7, pp. 426-439
Open Access | Times Cited: 111
A guide to complement biology, pathology and therapeutic opportunity
Dimitrios C. Mastellos, George Hajishengallis, John D. Lambris
Nature reviews. Immunology (2023) Vol. 24, Iss. 2, pp. 118-141
Closed Access | Times Cited: 101
Dimitrios C. Mastellos, George Hajishengallis, John D. Lambris
Nature reviews. Immunology (2023) Vol. 24, Iss. 2, pp. 118-141
Closed Access | Times Cited: 101